A total of 19 775 patients with clinically localized prostate cancer (PCa) who had undergone radical prostatectomy and pelvic lymph node dissection (PLND) were identified within the Surveillance Epidemiology and End Results (SEER) database. All four nomograms were tested using Heagerty's concordance index (C-index), calibration plots and decision curve analysis (DCA). In addition, we examined specific nomogram-derived thresholds to compare the number of avoided PLNDs and missed LNI-positive cases.
Objectives
To perform a head-to-head comparison of four nomograms; namely, the Cagiannos, the 2012-Briganti, the Godoy and the online-Memorial Sloan Kettering Cancer Center (MSKCC), for prediction of lymph node invasion (LNI) in a North American population.
Patients and Methods
A total of 19 775 patients with clinically localized prostate cancer (PCa) who had undergone radical prostatectomy and pelvic lymph node dissection (PLND) were identified within the Surveillance Epidemiology and End Results (SEER) database. All four nomograms were tested using Heagerty's concordance index (C-index), calibration plots and decision curve analysis (DCA). In addition, we examined specific nomogram-derived thresholds to compare the number of avoided PLNDs and missed LNI-positive cases.
Results
All nomograms were found to have highly comparable C-index values: the Cagiannos, 78.6%; the Godoy, 78.2%; the 2012-Briganti, 79.8%; and the MSKCC, 79.9%. The Cagiannos nomogram showed the best calibration, followed by the 2012-Briganti, the Godoy and the online-MSKCC. In DCA, the 2012-Briganti and the Cagiannos, in that order, provided the best results, followed by the Godoy and the online-MSKCC models. For each nomogram, the threshold associated with ≤10% missed LNI cases avoided 8 693 (46.6%), 8 652 (46.4%), 8 461 (45.4%) and 8 590 (46.1%) PLNDs, respectively, with the use of the Cagiannos (2.6% threshold), the online-MSKCC (4.3% threshold), the Godoy (3.6% threshold) and the 2012-Briganti (4.6% threshold) nomograms.
Introduction
Pelvic lymph node dissection (PLND) represents a compulsory component of a comprehensive radical prostatectomy (RP) for patients with clinically localized prostate cancer (PCa) [1, 2] . PLND may offer improved outcomes in terms of cancer control, especially in patients with oligometastatic disease manifested by one or two lymph nodes, and provides highly valuable staging information [3] [4] [5] ; however, PLND is also associated with potential complications and a longer operating time. In consequence, it is not invariably performed at all RPs and PLND recommendation may vary according to risk level derived from risk stratification tools [6, 7] .
According to the National Comprehensive Cancer Network (NCCN) guidelines, one nomogram (the Cagiannos [8] ) may be used to discriminate between patients in whom PLND is recommended or in whom PLND might be avoided [9] . Despite its value, this nomogram was developed more than 10 years ago on historical cohorts that may not be representative of contemporary patients.
Since the inception of the Cagiannos tool, two novel risk stratification tools, namely the Godoy [10] and the dynamic online-Memorial Sloan Kettering Cancer Center (MSKCC) calculator [11] , were introduced; however, neither has been externally validated. Additionally, despite five previous European external validations [12] [13] [14] [15] [16] of the 2006-Briganti [17] and of the 2012-Briganti [18] nomogram, neither has been externally validated in North American patients.
Similarly, none of the other three risk stratification tools developed for LNI risk prediction were ever externally validated in North American patients except for the Cagiannos nomogram, which was tested in patients treated with RP at the MSKCC between 2000 and 2008 [10] . To address this, we performed a head-to-head comparison of the four most important LNI nomograms; namely, the Cagiannos, the Godoy, the 2012-Briganti and the online-MSKCC within the most contemporary Surveillance Epidemiology and End Results (SEER) database, spanning the years 2010-2014.
Materials and Methods

Study Cohorts
In the SEER database, we focused on patients aged >18 years, diagnosed between 2010 and 2014 with histologically confirmed adenocarcinoma of the prostate (code 8140). Only individuals who underwent RP and PLND with complete data regarding clinical stage, biopsy Gleason score (GS) and preoperative PSA values were considered. Patients with locally advanced disease (pT4), PSA ≥50 ng/mL and metastatic disease (M1a/b/c) were excluded from the analyses. Further patient exclusion criteria were unknown clinical stage, unknown PSA, unknown biopsy GS, unknown number of positive or negative cores and unknown lymph node status. We relied on the SEER 2010-2014 data, which have the benefit of extensive data quality review including PSA values [19] .
Statistics
Descriptive statistics focused on frequencies and proportions for categorical variables. Means, medians and ranges were reported for continuously coded variables. The statistical significance of differences in medians and proportions was evaluated with the Kruskal-Wallis and chi-squared tests. All statistical tests were two-sided with P values < 0.05 taken to indicate statistical significance.
For the purpose of external validation, the predicted LNI risk was calculated for the three-variable Cagiannos, the Godoy and the 2012-Briganti LNI nomograms using the tools provided in the original reports [8, 10, 18] . The LNI probability according to the dynamic MSKCC risk calculator was obtained using the online coefficients and model properties [20] . Subsequently, the predicted LNI risk for each tool was compared with the observed LNI rate in the present study population. Analyses consisted of four steps.
First, the discrimination of the four examined tools was quantified using Heagerty's concordance index (C-index) [21] . Second, calibration plots were generated. The extent of overor underestimation was plotted for the four nomograms and the departures between observed calibration and ideal prediction were quantified for predicted probabilities of 5%, 10% and 30%, as well as for the highest individual nomogram prediction. Third, decision curve analysis (DCA) was used to ascertain the net benefit related to the use of the four examined nomograms [22] . Finally, we tabulated sensitivity, specificity, positive predictive value and negative predictive value, as well as the number of avoided PLNDs for each model. All calculations were performed considering a rate of LNI-positive cases missed by using the nomogram of ≤10%. Analyses were performed using R software (version 3.3.0; http://www.r-project.org/).
Results
Between 2010 and 2014, 19 775 men underwent RP and PLND. Their median (interquartile range [IQR]) age was 62 (57-66) years. Most were white (n = 14 077, 71.2%), married (n = 14 781, 74.7%), harboured clinical stage T1c disease (n = 14 771, 74.7%) and had biopsy GS 7 (n = 10 947, 55.3%). The median (IQR) PSA at diagnosis was 6.3 (4.8-9.6) ng/mL, the median (IQR) number of biopsy cores was 12 (12-13) and the median (IQR) number of positive cores was 4 (3-7; Table 1 ).
Overall, the median (IQR) number of lymph nodes removed was 6 (3-11), and 1 131 men (5.7%) had LNI. The men with LNI had higher median PSA values (9.9 vs 6.2 ng/mL), a higher clinical stage (cT2b+, 34.3% vs 14.4%), higher biopsy GS (GS 8, 52.8% vs 19.1%) and a higher median number of positive cores at biopsy (7.7 vs 4.9).
Concordance Index and Calibration Plots
In the C-index-based test, virtually the same values were recorded for all four nomograms: 78.6% for the Cagiannos; 78.2% for the Godoy; 79.8% for the 2012-Briganti; and 79.9% for the online-MSKCC model.
None of the four examined tools were found to have ideal calibration (Fig. 1) . The Cagiannos nomogram underestimated LNI rates. Conversely, the three other tools overestimated LNI rates based on the absolute magnitude of departures from ideal prediction that were recorded for all four tools, at 5%, 10% and 30% predicted probabilities, as well as for the highest nomogram predicted value. We observed the least pronounced departures from ideal predictions with the use of the Cagiannos nomogram. The absolute departures from ideal predictions were +2.8%, +5.6% and +2.7%, respectively, for 5%, 10% and 30% predicted probabilities. Of the remaining three tools that overestimated LNI rates, the 2012-Briganti showed the smallest departures: À2.4%, À3.5% and À12.8% at 5%, 10% and 30% predicted probability values. The second least important departures were recorded for the Godoy nomogram: À1.0%, À2.6% and À14.9% at 5%, 10% and 30% predicted probability values. The most pronounced departures were recorded for the online-MSKCC nomogram: À2.2%, À5.1% and À15.3% at 5%, 10% and 30% predicted probability values. The highest nomogram predicted probability values were 53.8%, 49.1%, 43.4% and 32.7%, respectively, for the online-MSKCC, the 2012-Briganti, the Godoy and the Cagiannos nomograms. It is notable that the Cagiannos nomogram's highest predicted probability value was 30%. Conversely, substantially higher maximum probability values were recorded for the online-MSKCC (94.8%), the 2012-Briganti (94.1%) and the Godoy (87.4%; Fig. 2 ).
Decision Curve Analysis
In DCA, which was used to quantify the net benefit related to the use of the four examined tools, the highest net benefit was recorded for the 2012-Briganti nomogram, except for threshold probabilities in excess of 12.5%, where the Cagiannos nomogram represented the dominant tool. The Godoy and the online-MSKCC nomograms yielded the second worst and worst results, respectively (Fig. 3) . Nonetheless, all four examined tools resulted in a net benefit compared to use of no risk stratification tool.
Probability Thresholds
We examined the nomogram performance according to a fixed threshold set at ≤10% for false-negative results (missed instances of LNI). Specifically, for each nomogram a threshold was examined that corresponded to ≤10% patients with histologically confirmed LNI that would have been For the Cagiannos, the Godoy, the 2012-Briganti and the online-MSKCC nomograms the thresholds corresponded to 2.6%, 3.6%, 4.6% and 4.3%. These would have resulted in 112 (9.9%), 111 (9.8%), 114 (10%) and 114 (10%) instances of missed LNI (false-negatives), respectively. For the same four nomograms, the use of the 10% threshold would have The associated sensitivity, specificity, positive and negative predictive values are shown in Table 2 . We also examined the nomogram performance according to a threshold set at 8% and 12% for false-negative results. Regardless of the threshold used, we obtained virtually the same results (Table S1 ).
Discussion
Four tools are available for the prediction of LNI in either North American or European patients [8, 10, 11, 18] ; however, only the Cagiannos and the 2006-Briganti nomograms are currently recommended by NCCN guidelines. This recommendation was made despite the availability of an update of the Briganti nomogram (2012-Briganti) and two additional novel LNI risk prediction tools: the Godoy and the online-MSKCC nomograms.
Based on the absence of direct comparisons among the Cagiannos, the Godoy, the 2012-Briganti and the online-MSKCC, we performed a head-to-head comparison. This resulted in several noteworthy findings.
First, discrimination tests showed that all four tools predicted almost equally well, as evidenced by C-index values, which ranged from 78.6% to 79.9%. In consequence, C-index values cannot be used to declare one tool superior to another. Moreover, the C-index results indicated that the relatively old Cagiannos nomogram exhibited virtually the same discrimination proprieties relative to its contemporary counterparts, the Godoy, the 2012-Briganti and the online-MSKCC nomograms.
In the second step of our analyses, we examined the calibration proprieties of each LNI prediction tool. Ideal performance was defined as perfect agreement between predicted and observed LNI rates. Of all four examined tools, the Cagiannos nomogram exhibited the smallest departures from ideal predictions. Specifically, the departures from ideal prediction at 5%, 10% and 30% predicted probability values ranged from +2.7% to +5.6%. The second best calibration was obtained for the 2012-Briganti nomogram, for which the departures from ideal prediction at 5%, 10% and 30% predicted probability values ranged from À2.4% to À12.8%, and its value was À45% at the highest predicted probability. The worst and the second worst were the online-MSKCC and the Godoy nomograms, with even more important departures from ideal predictions. Taken together, the calibration proprieties clearly indicated that the Cagiannos nomogram, despite its historical nature, provided the best calibration characteristics. This quality represents a very important consideration, when a tool is used in everyday clinical practice. In the absence of meaningful differences in recorded accuracy values, calibration tests represent a key benchmark for distinguishing between the most useful and least useful tool.
Third, the DCA represents another key benchmark to identify the most clinically useful tool among the four tested nomograms. In the DCA, the 2012-Briganti and the Cagiannos nomograms were found to have very similar performance. Higher net benefit was recorded for the 2012-Briganti nomogram for threshold probability values ranging from 9.2 to 12.5. Conversely, higher net benefit was recorded for the Cagiannos nomogram for the remaining threshold probability values. The remaining two tools, the Godoy and the online-MSKCC nomograms, were found to yield lower net benefit for all tested threshold probability values. Taken together, the Cagiannos and the 2012-Briganti nomograms emerged as the leaders in the DCA.
Fourth, analyses of four threshold values that focused on nomogram performance above and below the cut-off values set at 10% false-negative rate revealed striking similarities in the four examined models. Regarding potentially avoided PLNDs, the 10% false-negative rate threshold corresponded to the Cagiannos nomogram's predicted probability of 2.6%. The use of that 2.6% threshold would have avoided 8 693 (46.6%) PLNDs. Similarly, the use of the Godoy, the 2012-Briganti and the online-MSKCC predicted probability thresholds of It should also be noted that, with the exception of the Cagiannos nomogram, the other three models overestimated the actual LNI risk. Indeed, the highest LNI predicted probability values were 94.8%, 94.1% and 87.4%, respectively, for the online-MSKCC, the 2012-Briganti and the Godoy nomograms. Conversely, their actual probability values were 53.8%, 49.1% and 43.8%, for the aforementioned tools. This implies that the departures from ideal prediction for these models will be À41%, À45% and À44%, respectively, when the highest probability is predicted. This departure effect should be considered in the clinical decision-making process.
To the best of our knowledge, the present study is the first North American head-to-head comparison between the four LNI prediction tools. . Fourth, we relied on the SEER database, which has an impressive sample size, but is limited by lack of detailed patient information that is usually available in high-quality prospective institutional databases from tertiary care institutions. Nonetheless, the accuracy values that we report validate the quality of the SEER data. Fifth, we opted to limit our comparison to the four LNI prediction tools that have previously demonstrated the highest value in external validation studies [10, 15, 16] or that are widely used in everyday clinical practice [20] . Finally, despite several comprehensive analytical steps, the present analysis does not prove that one nomogram better discriminates than another. Rather, the performance of each nomogram may be better or worse depending on clinical circumstances, including which patients are considered candidates for RP and PLND.
In conclusion, the Cagiannos and the Briganti nomograms exhibited the best performance characteristics in the DCA. Conversely, the accuracy values for predicting LNI and the ability to avoid unnecessary PLNDs were virtually the same for all four examined tools. In consequence, the Cagiannos and the 2012-Briganti nomograms should be considered the best tools for prediction of LNI in North American patients.
